FAST Company

Seismic Bio

Seismic Bio, Inc. is an emerging preclinical-stage biopharmaceutical company developing bispecific therapeutic antibodies that enable controlled activation of the immune system to fight cancer.  The company is committed to advancing the field of immuno-oncology, with a focus on treating solid tumor types that fail to respond to immune checkpoint inhibitors.  Using cutting-edge science at the intersection of genomics and immunology, Seismic Bio is creating best-in-class therapeutic bispecific antibodies that will provide tuned and targeted stimulation to the immune system, ensuring broad therapeutic windows. The company is founded and financed by industry veterans, and it is based in the San Francisco Bay Area.